CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
Orion daily disposable contact lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04585646
NCT04585646N/ACompleted

A Two-Week Crossover Dispensing Evaluation Of Orion Daily Wear Soft Contact Lens

CooperVision, Inc.·interventional·Posted Oct 14, 2020·Updated May 10, 2022

In Brief

A clinical study evaluating Orion daily disposable contact lens and Gemini daily disposable contact lens for Myopia. Completed, enrolled 64 participants across 1 site.

Detailed Summary

The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 14, 2020
Enrollment StartSep 14, 2020
Primary CompletionNov 30, 2020
Study CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.7 years ago

Interventions

Orion daily disposable contact lensdevice

Subjects will be randomized to wear Orion lens for 2 weeks.

Gemini daily disposable contact lensdevice

Subjects will be randomized to wear Gemini lens for 2 weeks.